Allergan Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (47)

Latest Posts

About This Stock More About This Stock
Four Consecutive Trading Sessions With Record Highs
Article By: Marvin R Clark
Tuesday, February 14, 2017 11:31 PM EST
Federal Reserve Chair Janet Yellen said the labor market is basically where the Fed wants it to be, and inflation is just a little lower than their target.
In this article: AET, AGN, CI, CS, FCX, GM, HUM, T, VZ, TOSBF, CYNO, HOLX, ZLTQ, TMUS, ANTM, QSR, PLKI, LITE
Read
E Allergan To Acquire Zeltiq Aesthetics For $2.48B, $56.50 Per Share
Article By: Jacob Maslow
Tuesday, February 14, 2017 6:39 AM EST
Allergan announced on Monday that the company will acquire Zeltiq Aesthetics in a $2.48 billion deal. The company's failed merger with Pfizer Inc. last year has led to Allergen Chief Executive Brent Saunders acquiring several companies.
In this article: AGN, ZLTQ Also: PFE
Read
Wall Street Hit Record Highs Again
Article By: Marvin R Clark
Monday, February 13, 2017 11:56 PM EST
Wall Street hit record highs again. Stock markets around the world were higher this morning. The S&P 500’s market value topped $20 trillion.
In this article: AGN, DIS, TOSBF, ORCL, ZLTQ, JJC, GOOGL
Read
Allergan Plc. Announces Intention To Acquire Zeltiq Aesthetics
Article By: Lorimer Wilson
Monday, February 13, 2017 12:12 PM EST
Pharma giant Allergan plc. is adding another line of cosmetic treatments to its portfolio, announcing today that it will acquire body contouring specialist ZELTIQ Aesthetics for nearly $2.5 billion in cash.
In this article: AGN, ZLTQ
Read
Another Record High For The Nasdaq Composite
Article By: Marvin R Clark
Wednesday, February 8, 2017 10:50 PM EST
Another record high for the Nasdaq Composite, its 12th all-time close of 2017.
In this article: AGN, ALK, BA, BAC, DAL, GS, HUM, SYT, T, TWX, AIDEF, EADSF, VLKAF, INTC, MCHP, PNRA
Read

PARTNER HEADLINES

Latest Tweets for $AGN

No tweets yet!

$AGN

Valeant Edges Up 15% After Announcing That It Will Acquire Salix
Terry Caruso 2/24/2015 8:20:44 PM

You said the company tried to acquire Allergan but the deal fell through because Valeant didn't like it's large R&D program. If true, why did it try to acquire $AGN in the first place?

1 to 1 of 1 comments